Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
A
ll mammalian life is depen- needs of the fetus and placenta. Addi- Iron deficiency anemia
dent on a continuous supply tional iron is needed to expand mater- may be associated with
of molecular oxygen. Molec- nal red blood cell volume and replace adverse pregnancy
ular oxygen is carried to cells by non- iron lost due to bleeding at delivery. outcomes
covalent binding to the iron moiety in In the National Health and Nutrition In a retrospective study of
the hemoglobin of red blood cells. It Examination Survey (NHANES) of 75,660 singleton pregnancies,
is utilized within cells by noncovalent 1988–1994, 11% of women aged 16 to 7,977 women were diagnosed with
binding to the iron moiety in various 49 years were iron deficient. By con- iron deficiency anemia when they
microsomal and mitochondrial pro- trast, less than 1% of men aged 16 to were admitted for delivery. Com-
teins, including myoglobin and cyto- 49 years were iron deficient.1 pared with pregnant women without
chromes. Consequently, to efficiently In a NHANES study from 1999– iron deficiency, the presence of iron
utilize molecular oxygen all mamma- 2006, risk factors for iron deficiency deficiency increased the risk of:
lian life is dependent on an adequate included multiparity, current preg- • blood transfusion (odds ratio [OR],
supply of iron. Surprisingly, in an era nancy, and regular menstrual cycles. 5.48; 95% confidence interval [CI],
of high technology precision medi- Use of hormonal contraception 4.57–6.58)
cine, many pregnant women are iron reduced the rate of iron deficiency.2 • preterm delivery (OR, 1.54; 95% CI,
deficient, anemic, and not receiving Using the same data, the prevalences 1.36–1.76)
adequate iron supplementation. of iron deficiency during the first, • cesarean delivery (OR, 1.30; 95%
second, and third trimesters of preg- CI, 1.13–1.49)
nancy were reported to be 7%, 14%, • 5-minute Apgar score <7 (OR, 2.21;
Iron deficiency is and 30%, respectively.3 In addition 95% CI, 1.84–2.64)
prevalent in women and to pregnancy and menstrual bleeding • intensive care unit (ICU) admission
pregnant women there are many other medical prob- (OR, 1.28; 95% CI, 1.20–1.39).4
Women often become iron deficient lems that may contribute to iron defi- In a systematic review and meta-
because of pregnancy or heavy men- ciency, including Helicobacter pylori analysis of 26 studies, maternal ane-
strual bleeding. During pregnancy, (H pylori) infection, gastritis, celiac mia (mostly iron deficiency anemia)
maternal iron is provided to supply the disease, and bariatric surgery. was associated with a higher risk of
CONTINUED ON PAGE 10
treatment with IV iron may be espe- (200 mg per infusion, with 5 infu- access of pregnant women to IV
cially appropriate for women with sions over many days), some centers iron treatment, obstetricians need
iron deficiency anemia in the third have explored the use of 1 large dose to work with hematologists and
trimester of pregnancy. Prior gastric of IV iron (1,000 mg of low molecu- infusion centers to create collabora-
surgery, including gastric bypass, lar weight iron dextran adminis- tive protocols to expeditiously treat
results in reduced gastric acid pro- tered over 1 hour) (INFeD, Watson women in the third trimester.
duction and causes severe impair- Pharma).17–19 This is not a regimen There is an epidemic of iron
ment of intestinal absorption of iron. that is specifically approved by the deficiency in pregnant women in
Patients with malabsorption syn- US Food and Drug Administration. the United States. In an era of high
dromes, including celiac disease, also An alternative regimen is to adminis- technology medicine, it is surpris-
may have limited absorption of oral ter 750 mg of ferrous carboxymaltose ing that iron deficiency remains an
iron. These populations of pregnant (Injectafer, Luitpold Pharmaceuti- unsolved obstetric problem in our
women may particularly benefit from cals) over 15 minutes, which is an country.
the use of IV iron. In pregnant women FDA-approved regimen.18 Many
IV iron has fewer gastrointestinal side hematologists prefer to adminis-
effects than oral iron.16 ter multiple smaller doses of iron.
Many severely iron deficient For example, in our practice, preg-
patients need 1,000 mg of iron to nant women are commonly treated RBARBIERI@FRONTLINEMEDCOM.COM
resolve their deficit. In order to with IV iron sucrose (300 mg) every The authors report no financial relationships rel-
avoid giving multiple standard doses 2 weeks for 3 doses. To increase evant to this article.
References
1. Looker AC, Dallman PR, Carroll MD, Gunter EW, 7. Guyatt GH, Oxman AD, Ali M, Willan A, McIl- iron supplementation during pregnancy. Cochrane
Johnson CL. Prevalence of iron deficiency in the roy W, Patterson C. Laboratory diagnosis of Database Syst Rev. 2015(10);CD009997.
United States. JAMA. 1997;277(12):973–976. iron-deficiency: an overview. J Gen Intern Med. 14. Moretti D, Goede JS, Zeder C, et al. Oral iron supple-
2. Miller EM. Iron status and reproduction in US 1992;7(2):145–153. ments increase hepcidin and decrease iron absorp-
women: National Health and Nutrition Examination 8. van den Broek NR, Letsky EA, White SA, Shenkin tion from daily or twice-daily doses in iron-depleted
Survey 1999–2006. PLoS One. 2014;9(11):e112216. A. Iron status in pregnant women: which measure- young women. Blood. 2015;126(17):1981–1989.
3. Mei Z, Cogswell ME, Looker AC, et al. Assess- ments are valid? Br J Haematol. 1998;103(3):817– 15. Schrier SL. So you know how to treat iron deficiency
ment of iron status in US pregnant women from 824. anemia. Blood. 2015;126(17):1971.
the National Health and Nutrition Examination 9. Peña-Rosas JP, De-Regil LM, Garcia-Casal MN, 16. Breymann C, Milman N, Mezzacasa A, Bernard
Survey (NHANES), 1999–2006. Am J Clin Nutr. Dowswell T. Daily oral iron supplementation R, Dudenhausen J; FER-ASAP investigators. Fer-
2011;93(6):1312–1320. during pregnancy. Cochrane Database Syst Rev. ric carboxymaltose vs oral iron in the treatment
4. Drukker L, Hants Y, Farkash R, Ruchlemer R, Samu- 2015(7);CD004736. of pregnant women with iron deficiency ane-
eloff A, Grisaru-Granovsky S. Iron deficiency ane- 10. Cantor AG, Bougatsos C, Dana T, Blazina I, mia: an international, open-label, randomized
mia at admission for labor and delivery is associ- McDonagh M. Routine iron supplementation and controlled trial (FER-ASAP). J Perinatal Med.
ated with an increased risk for Cesarean section and screening for iron deficiency anemia in pregnancy: 2017;45(4):443–453.
adverse maternal and neonatal outcomes. Transfu- a systematic review for the US Preventive Services 17. Auerbach M, Pappadakis JA, Bahrain H, Auer-
sion. 2015;55(12):2799–2806. Task Force. Ann Intern Med. 2015;162(8):566–576. bach SA, Ballard H, Dahl NV. Safety and efficacy
5. Rahmann MM, Abe SK, Rahman MS, et al. Mater- 11. Centers for Disease Control and Prevention. Rec- of rapidly administered (one hour) one gram of
nal anemia and risk of adverse birth and health ommendations to prevent and control iron defi- low molecular weight iron dextran (INFeD) for the
outcomes in low- and middle-income countries: ciency in the United States. MMWR Recomm Rep. treatment of iron deficient anemia. Am J Hematol.
systematic review and meta-analysis. Am J Clin 1998;47(RR-3):1–29. 2011;86(10):860–862.
Nutr. 2016;103(2):495–504. 12. Tolkien Z, Stecher L, Mander AP, Pereira DI, Pow- 18. Auerbach M, Adamson JW. How we diagnose
6. Zeng L, Dibley MJ, Cheng Y, et al. Impact of micro- ell JJ. Ferrous sulfate supplementation causes sig- and treat iron deficiency anemia. Am J Hematol.
nutrient supplementation during pregnancy nificant gastrointestinal side-effects in adults: a 2016;91(1):31–38.
on birth weight, duration of gestation, and peri- systematic review and meta-analysis. PLoS One. 19. Wong L, Smith S, Gilstrop M, et al. Safety and effi-
natal mortality in rural western China: double 2015;10(2):e0117383. cacy of rapid (1,000 mg in 1 hr) intravenous iron dex-
blind cluster randomised controlled trial. BMJ. 13. Peña-Rosas JP, De-Regil LM, Gomez Malave H, tran for treatment of maternal iron deficient anemia
2008;337:a2001. Flores-Urrutia MC, Dowswell T. Intermittent oral of pregnancy. Am J Hematol. 2016;91(6):590–593.